Coinspeaker BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine TrialsShanghai Fosun Pharmaceutical Industrial Development received the acceptance notice of clinical trial application for the COVID-19 vaccine candidate BNT162b1 created by BioNTech.BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine Trials